NEW CASTLE – Frontier Airlines, the discount airline that restarted Delaware’s only passenger service out of New Castle Airport in February, finalized its initial public offering Thursday, raising $266 million in its market entry. The ...
NEW CASTLE – Frontier Airlines, the discount airline that restarted Delaware’s only passenger service out of New Castle Airport in February, filed for an initial public offering Monday, seeking to raise upward of $100 million ...
Kris Vaddi Founder and CEO, Prelude Therapeutics When Kris Vaddi and his team at Prelude Therapeutics decided to take their specialty cancer drug development company public, he never dreamed that it would turn into a ...
WILMINGTON – After weeks of waiting and behind-the-scenes negotiating, Prelude Therapeutics closed its initial public offering Thursday night at its highest targeted price point of $19 a share, resulting in $158.2 million in proceeds. Prelude, ...
WILMINGTON – Prelude Therapeutics, a private biotechnology startup company headquartered at the Delaware Innovation Space, has set its sights on a $150 million initial public offering (IPO), increasing the sale by about 50% from its ...
WILMINGTON – Fresh off Series C funding closed last month, Prelude Therapeutics, a private life sciences start-up company headquartered in Alapocas, has announced that it is pursuing an initial public offering (IPO) worth as much ...
